Tight junctions in brain barriers during central nervous system inflammation.
暂无分享,去创建一个
[1] L. Mitchell,et al. Claudins: control of barrier function and regulation in response to oxidant stress. , 2011, Antioxidants & redox signaling.
[2] Bernhard Hennig,et al. Oxidative stress and blood-brain barrier dysfunction under particular consideration of matrix metalloproteinases. , 2011, Antioxidants & redox signaling.
[3] I. Blasig,et al. Occludin protein family: oxidative stress and reducing conditions. , 2011, Antioxidants & redox signaling.
[4] G. Bazzoni. Pathobiology of junctional adhesion molecules. , 2011, Antioxidants & redox signaling.
[5] D. Antonetti,et al. Alterations to the blood-retinal barrier in diabetes: cytokines and reactive oxygen species. , 2011, Antioxidants & redox signaling.
[6] Mónica Díaz-Coránguez,et al. ZO proteins and redox-dependent processes. , 2011, Antioxidants & redox signaling.
[7] I. Ferrer,et al. Aβ accumulation in choroid plexus is associated with mitochondrial-induced apoptosis , 2010, Neurobiology of Aging.
[8] E. V. Van Bockstaele,et al. HIV-1 gp120-Induced Injury to the Blood-Brain Barrier: Role of Metalloproteinases 2 and 9 and Relationship to Oxidative Stress , 2010, Journal of neuropathology and experimental neurology.
[9] Hyoung-Gon Lee,et al. Antioxidant approaches for the treatment of Alzheimer’s disease , 2010, Expert review of neurotherapeutics.
[10] S. Milatz,et al. Claudin-2, a component of the tight junction, forms a paracellular water channel , 2010, Journal of Cell Science.
[11] E. V. Bockstaele,et al. Blood–brain barrier abnormalities caused by exposure to HIV-1 gp120 — Protection by gene delivery of antioxidant enzymes , 2010, Neurobiology of Disease.
[12] H. Galla,et al. Metalloproteinase mediated occludin cleavage in the cerebral microcapillary endothelium under pathological conditions , 2010, Brain Research.
[13] A. Fujimura,et al. Claudin-2–deficient mice are defective in the leaky and cation-selective paracellular permeability properties of renal proximal tubules , 2010, Proceedings of the National Academy of Sciences.
[14] B. Becher,et al. Cellular mechanisms of IL‐17‐induced blood‐brain barrier disruption , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[15] K. Hirata,et al. Interaction of endothelial cell‐selective adhesion molecule and MAGI‐1 promotes mature cell–cell adhesion via activation of RhoA , 2010, Genes to cells : devoted to molecular & cellular mechanisms.
[16] K. Plate,et al. Differentiation of the brain vasculature: the answer came blowing by the Wnt , 2010, Journal of angiogenesis research.
[17] B. Engelhardt,et al. The blood–brain and the blood–cerebrospinal fluid barriers: function and dysfunction , 2009, Seminars in Immunopathology.
[18] D. Antonetti,et al. Occludin Phosphorylation and Ubiquitination Regulate Tight Junction Trafficking and Vascular Endothelial Growth Factor-induced Permeability* , 2009, The Journal of Biological Chemistry.
[19] J. Ghersi-Egea,et al. The Role of the Choroid Plexus in Neutrophil Invasion after Traumatic Brain Injury , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[20] B. Engelhardt,et al. C-C chemokine receptor 6–regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE , 2009, Nature Immunology.
[21] I. Romero,et al. Amyloid-β-induced occludin down-regulation and increased permeability in human brain endothelial cells is mediated by MAPK activation , 2009, Journal of cellular and molecular medicine.
[22] Berislav V. Zlokovic,et al. Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease , 2009, Acta Neuropathologica.
[23] M. Mohsenzadegan,et al. Antioxidant therapy in multiple sclerosis , 2009, Immunopharmacology and immunotoxicology.
[24] Elisabetta Dejana,et al. The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. , 2009, Developmental cell.
[25] L. Nencioni,et al. GSH and analogs in antiviral therapy. , 2009, Molecular aspects of medicine.
[26] M. Bewley,et al. Identification and analysis of occludin phosphosites: a combined mass spectrometry and bioinformatics approach. , 2009, Journal of proteome research.
[27] H. D. de Vries,et al. Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression. , 2008, Free radical biology & medicine.
[28] D. Praticò. Oxidative stress hypothesis in Alzheimer's disease: a reappraisal. , 2008, Trends in pharmacological sciences.
[29] Xiongwei Zhu,et al. Antioxidant therapy in Alzheimer's disease: theory and practice. , 2008, Mini reviews in medicinal chemistry.
[30] Aaron J. Johnson,et al. Induction of Blood Brain Barrier Tight Junction Protein Alterations by CD8 T Cells , 2008, PloS one.
[31] Alberto Romagnolo,et al. Involvement of the choroid plexus in multiple sclerosis autoimmune inflammation: A neuropathological study , 2008, Journal of Neuroimmunology.
[32] R. Sutliff,et al. The Roles of HIV-1 Proteins and Antiretroviral Drug Therapy in HIV-1-Associated Endothelial Dysfunction , 2008, Journal of Investigative Medicine.
[33] N. Schaeren-Wiemers,et al. RNA profiling of MS brain tissues. , 2008, International MS journal.
[34] M. Yano,et al. Human immunodeficiency virus type 1 gp120-mediated disruption of tight junction proteins by induction of proteasome-mediated degradation of zonula occludens-1 and -2 in human brain microvascular endothelial cells , 2008, Journal of NeuroVirology.
[35] J. Piontek,et al. Structure and function of claudins. , 2008, Biochimica et biophysica acta.
[36] T. Kiyota,et al. Phosphorylation of claudin-5 and occludin by rho kinase in brain endothelial cells. , 2008, The American journal of pathology.
[37] B. Wiesner,et al. Formation of tight junction: determinants of homophilic interaction between classic claudins , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[38] R. Gonsette. Review: Oxidative stress and excitotoxicity: a therapeutic issue in multiple sclerosis? , 2008, Multiple sclerosis.
[39] M. Toborek,et al. Limited role of COX-2 in HIV Tat-induced alterations of tight junction protein expression and disruption of the blood–brain barrier , 2007, Brain Research.
[40] H. D. Vries,et al. Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology , 2007, Brain Research Reviews.
[41] Nathalie Arbour,et al. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation , 2007, Nature Medicine.
[42] M. Moss,et al. Soluble aggregates of the amyloid‐β protein activate endothelial monolayers for adhesion and subsequent transmigration of monocyte cells , 2007, Journal of neurochemistry.
[43] L. Rivers,et al. Inflammation and dephosphorylation of the tight junction protein occludin in an experimental model of multiple sclerosis , 2007, Neuroscience.
[44] J. Newcombe,et al. Peroxiredoxin V in multiple sclerosis lesions: predominant expression by astrocytes , 2007, Multiple sclerosis.
[45] M. Eisenstein,et al. OSP/claudin‐11‐induced EAE in mice is mediated by pathogenic T cells primarily governed by OSP192Y residue of major encephalitogenic region OSP179–207 , 2007, European journal of immunology.
[46] James M. Anderson,et al. The unique-5 and -6 motifs of ZO-1 regulate tight junction strand localization and scaffolding properties. , 2007, Molecular biology of the cell.
[47] S. McQuaid,et al. Persistent endothelial abnormalities and blood–brain barrier leak in primary and secondary progressive multiple sclerosis , 2007, Neuropathology and applied neurobiology.
[48] S. McQuaid,et al. Differences in expression of junctional adhesion molecule-A and β-catenin in multiple sclerosis brain tissue: increasing evidence for the role of tight junction pathology , 2007, Acta Neuropathologica.
[49] D. Vestweber,et al. Junctional adhesion molecule-a participates in the formation of apico-basal polarity through different domains. , 2006, Experimental cell research.
[50] Caroline Anderson,et al. Oxidative stress and therapeutic approaches in HIV dementia. , 2006, Antioxidants & redox signaling.
[51] R. Musters,et al. Lipoic Acid Affects Cellular Migration into the Central Nervous System and Stabilizes Blood-Brain Barrier Integrity1 , 2006, The Journal of Immunology.
[52] S. Butz,et al. ESAM supports neutrophil extravasation, activation of Rho, and VEGF-induced vascular permeability , 2006, The Journal of experimental medicine.
[53] K. Kaibuchi,et al. Rho-mediated regulation of tight junctions during monocyte migration across the blood-brain barrier in HIV-1 encephalitis (HIVE). , 2006, Blood.
[54] H. Edelhauser,et al. Antibody blockade of junctional adhesion molecule-A in rabbit corneal endothelial tight junctions produces corneal swelling. , 2006, Investigative ophthalmology & visual science.
[55] R. Jacob,et al. Vitamins C and E in adolescents and young adults with HIV infection. , 2006, The American journal of clinical nutrition.
[56] S. Tsukita,et al. Claudins in occluding junctions of humans and flies. , 2006, Trends in cell biology.
[57] A. Suzuki,et al. The PAR-aPKC system: lessons in polarity , 2006, Journal of Cell Science.
[58] J. Ghersi-Egea,et al. Brain Protection at the Blood–Cerebrospinal Fluid Interface Involves a Glutathione-Dependent Metabolic Barrier Mechanism , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[59] J. Greenwood,et al. Blood‐brain barrier‐specific properties of a human adult brain endothelial cell line , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[60] J. Firth,et al. Cadherin-10 is a novel blood–brain barrier adhesion molecule in human and mouse , 2005, Brain Research.
[61] M. Toborek,et al. HIV-1 Tat Protein-Induced Alterations of ZO-1 Expression are Mediated by Redox-Regulated ERK1/2 Activation , 2005 .
[62] B. Engelhardt,et al. The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. , 2005, Trends in immunology.
[63] M. Toborek,et al. Signaling Mechanisms of HIV-1 Tat-Induced Alterations of Claudin-5 Expression in Brain Endothelial Cells , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[64] L. Fenart,et al. Mouse syngenic in vitro blood–brain barrier model: a new tool to examine inflammatory events in cerebral endothelium , 2005, Laboratory Investigation.
[65] P. Grammas,et al. HIV-1 gp120 Proteins Alter Tight Junction Protein Expression and Brain Endothelial Cell Permeability: Implications for the Pathogenesis of HIV-Associated Dementia , 2005, Journal of neuropathology and experimental neurology.
[66] M. Ryan,et al. Occludin: structure, function and regulation. , 2005, Advanced drug delivery reviews.
[67] C. Teunissen,et al. Macrophages and neurodegeneration , 2005, Brain Research Reviews.
[68] B. Engelhardt,et al. Diapedesis of mononuclear cells across cerebral venules during experimental autoimmune encephalomyelitis leaves tight junctions intact , 2005, Acta Neuropathologica.
[69] K. Kim,et al. Hydrogen peroxide-induced alterations of tight junction proteins in bovine brain microvascular endothelial cells. , 2004, Microvascular research.
[70] C. Carman,et al. A transmigratory cup in leukocyte diapedesis both through individual vascular endothelial cells and between them , 2004, The Journal of cell biology.
[71] S. Butz,et al. Endothelial adhesion molecule ESAM binds directly to the multidomain adaptor MAGI-1 and recruits it to cell contacts. , 2004, Experimental cell research.
[72] C. Parkos,et al. Involvement of the Junctional Adhesion Molecule-1 (JAM1) Homodimer Interface in Regulation of Epithelial Barrier Function* , 2004, Journal of Biological Chemistry.
[73] A. Prigent-Tessier,et al. Differential MnSOD and HO-1 expression in cerebral endothelial cells in response to sublethal oxidative stress , 2004, Brain Research.
[74] R. Nardacci,et al. Immunohistochemical Localization of Peroxisomal Enzymes During Rat Embryonic Development , 2004, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[75] Elisabetta Dejana,et al. Endothelial cell–cell junctions: happy together , 2004, Nature Reviews Molecular Cell Biology.
[76] T. Terasaki,et al. A pericyte‐derived angiopoietin‐1 multimeric complex induces occludin gene expression in brain capillary endothelial cells through Tie‐2 activation in vitro , 2004, Journal of neurochemistry.
[77] L. Roccatagliata,et al. α-Lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis , 2004, Journal of Neuroimmunology.
[78] B. Engelhardt,et al. Astrocyte mediated modulation of blood-brain barrier permeability does not correlate with a loss of tight junction proteins from the cellular contacts , 2004, Cell and Tissue Research.
[79] D. Vestweber,et al. Junctional adhesion molecules (JAMs): more molecules with dual functions? , 2004, Journal of Cell Science.
[80] D. Dickstein,et al. Blood—Brain Barrier Permeability Precedes Senile Plaque Formation in an Alzheimer Disease Model , 2003 .
[81] Alireza Minagar,et al. Blood-brain barrier disruption in multiple sclerosis , 2003, Multiple sclerosis.
[82] H. Gendelman,et al. Mononuclear phagocyte immunity and the neuropathogenesis of HIV‐1 infection , 2003, Journal of leukocyte biology.
[83] Bernhard Hennig,et al. HIV‐1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells , 2003, Journal of neuroscience research.
[84] R. Reynolds,et al. Molecular Changes in Normal Appearing White Matter in Multiple Sclerosis are Characteristic of Neuroprotective Mechanisms Against Hypoxic Insult , 2003, Brain pathology.
[85] S. McQuaid,et al. Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood–brain barrier leakage and active demyelination , 2003, The Journal of pathology.
[86] Yong Woo Lee,et al. HIV-1 tat protein upregulates inflammatory mediators and induces monocyte invasion into the brain , 2003, Molecular and Cellular Neuroscience.
[87] A. Vorbrodt,et al. Molecular anatomy of intercellular junctions in brain endothelial and epithelial barriers: electron microscopist’s view , 2003, Brain Research Reviews.
[88] S. Tsukita,et al. Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice , 2003, The Journal of cell biology.
[89] Yong Woo Lee,et al. HIV‐Tat protein induces oxidative and inflammatory pathways in brain endothelium , 2002, Journal of neurochemistry.
[90] D. Bourdette,et al. Alpha lipoic acid inhibits T cell migration into the spinal cord and suppresses and treats experimental autoimmune encephalomyelitis , 2002, Journal of Neuroimmunology.
[91] P. Annunziata,et al. Circulating gp120 alters the blood–brain barrier permeability in HIV-1 gp120 transgenic mice , 2002, Neuroscience Letters.
[92] Hartwig Wolburg,et al. Tight junctions of the blood-brain barrier: development, composition and regulation. , 2002, Vascular pharmacology.
[93] B. Kuster,et al. A Transmembrane Tight Junction Protein Selectively Expressed on Endothelial Cells and Platelets* , 2002, The Journal of Biological Chemistry.
[94] M. Graves,et al. Cyclooxygenase-2-positive Macrophages Infiltrate the Alzheimer's Disease Brain and Damage the Blood–brain Barrier Pathology and Laboratory , 2022 .
[95] S. McQuaid,et al. Abnormal Endothelial Tight Junctions in Active Lesions and Normal‐appearing White Matter in Multiple Sclerosis , 2002, Brain pathology.
[96] Tetsuo Noda,et al. Claudin-based tight junctions are crucial for the mammalian epidermal barrier , 2002, The Journal of cell biology.
[97] D. Praticò. Alzheimer's disease and oxygen radicals: new insights. , 2002, Biochemical pharmacology.
[98] B. Engelhardt,et al. Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice. , 2002, The Journal of clinical investigation.
[99] F. Winkler,et al. X‐ray structure of junctional adhesion molecule: structural basis for homophilic adhesion via a novel dimerization motif , 2001, The EMBO journal.
[100] M. Itoh,et al. Junctional adhesion molecule (JAM) binds to PAR-3 , 2001, The Journal of cell biology.
[101] P. Adamson,et al. Reactive oxygen species enhance the migration of monocytes across the blood‐brain barrier in vitro , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[102] B. Engelhardt,et al. Claudin-1, claudin-2 and claudin-11 are present in tight junctions of choroid plexus epithelium of the mouse , 2001, Neuroscience Letters.
[103] C. Brosnan,et al. Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions. , 2001, The American journal of pathology.
[104] Shoichiro Tsukita,et al. Multifunctional strands in tight junctions , 2001, Nature Reviews Molecular Cell Biology.
[105] K. Khalili,et al. Cooperative Interaction between HIV-1 Regulatory Proteins Tat and Vpr Modulates Transcription of the Viral Genome* , 2000, The Journal of Biological Chemistry.
[106] G. Pendl,et al. Junctional adhesion molecule interacts with the PDZ domain-containing proteins AF-6 and ZO-1. , 2000, The Journal of biological chemistry.
[107] S. Liebner,et al. Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme , 2000, Acta Neuropathologica.
[108] J. Verhoef,et al. Monocyte infiltration is highly associated with loss of the tight junction protein zonula occludens in HIV‐1‐associated dementia , 2000, Neuropathology and applied neurobiology.
[109] F. Orsenigo,et al. Interaction of Junctional Adhesion Molecule with the Tight Junction Components ZO-1, Cingulin, and Occludin* , 2000, The Journal of Biological Chemistry.
[110] H. Wolburg,et al. Tight Junctions of the Blood–Brain Barrier , 2000, Cellular and Molecular Neurobiology.
[111] C. Patlak,et al. In Vitro Evidence That β‐Amyloid Peptide 1–40 Diffuses Across the Blood–Brain Barrier and Affects Its Permeability , 2000, Journal of neuropathology and experimental neurology.
[112] C. Achim,et al. Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. , 1999, The American journal of pathology.
[113] S. Tsukita,et al. Manner of Interaction of Heterogeneous Claudin Species within and between Tight Junction Strands , 1999, The Journal of cell biology.
[114] S. Tsukita,et al. Endothelial Claudin , 1999, The Journal of cell biology.
[115] M. Itoh,et al. Structural and signalling molecules come together at tight junctions. , 1999, Current opinion in cell biology.
[116] M. Corada,et al. Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[117] S. Tsukita,et al. Occludin and claudins in tight-junction strands: leading or supporting players? , 1999, Trends in cell biology.
[118] G. Ellison,et al. A humoral response to oligodendrocyte-specific protein in MS , 1999, Neurology.
[119] S. Bamforth,et al. A dominant mutant of occludin disrupts tight junction structure and function. , 1999, Journal of cell science.
[120] K. Fujimoto,et al. Claudin-11/OSP-based Tight Junctions of Myelin Sheaths in Brain and Sertoli Cells in Testis , 1999, The Journal of cell biology.
[121] B. Engelhardt,et al. Ultrastructural localization of adhesion molecules in the healthy , 1999, Cell and Tissue Research.
[122] S. Croul,et al. Molecular pathway involved in HIV‐1‐induced CNS pathology: role of viral regulatory protein, Tat , 1999, Journal of leukocyte biology.
[123] R Kemler,et al. Cadherins and tissue formation: integrating adhesion and signaling , 1999, BioEssays : news and reviews in molecular, cellular and developmental biology.
[124] K. Fujimoto,et al. Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[125] D. Roos,et al. Reactive oxygen species are required for the phagocytosis of myelin by macrophages , 1998, Journal of Neuroimmunology.
[126] K. Fujimoto,et al. A Single Gene Product, Claudin-1 or -2, Reconstitutes Tight Junction Strands and Recruits Occludin in Fibroblasts , 1998, The Journal of cell biology.
[127] R. Schmidt,et al. Peroxynitrite formation within the central nervous system in active multiple sclerosis , 1998, Journal of Neuroimmunology.
[128] E. Dejana,et al. Junctional Adhesion Molecule, a Novel Member of the Immunoglobulin Superfamily That Distributes at Intercellular Junctions and Modulates Monocyte Transmigration , 1998, The Journal of cell biology.
[129] V. Perry,et al. Loss of the tight junction proteins occludin and zonula occludens-1 from cerebral vascular endothelium during neutrophil-induced blood–brain barrier breakdown in vivo , 1998, Neuroscience.
[130] M. Smith,et al. Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo. , 1998, The American journal of pathology.
[131] M. Freedman,et al. Increased Peroxidation and Reduced Antioxidant Enzyme Activity in Alzheimer's Disease , 1998, Experimental Neurology.
[132] L. Rubin,et al. Occludin as a possible determinant of tight junction permeability in endothelial cells. , 1997, Journal of cell science.
[133] B R Johansson,et al. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. , 1997, Science.
[134] D. Hinton,et al. Extensive peroxynitrite activity during progressive stages of central nervous system inflammation , 1997, Journal of Neuroimmunology.
[135] J. Inazawa,et al. Mammalian occludin in epithelial cells: its expression and subcellular distribution. , 1997, European journal of cell biology.
[136] V. Perry,et al. Age-related effects of interleukin-1 beta on polymorphonuclear neutrophil-dependent increases in blood-brain barrier permeability in rats. , 1997, Brain : a journal of neurology.
[137] C. Patlak,et al. Fate of Cerebrospinal Fluid‐Borne Amyloid β‐Peptide: Rapid Clearance into Blood and Appreciable Accumulation by Cerebral Arteries , 1996, Journal of neurochemistry.
[138] B. Engelhardt,et al. ICAM-1, VCAM-1, and MAdCAM-1 are expressed on choroid plexus epithelium but not endothelium and mediate binding of lymphocytes in vitro. , 1996, The American journal of pathology.
[139] F. Breviario,et al. Molecular cloning and expression of murine vascular endothelial-cadherin in early stage development of cardiovascular system. , 1996, Blood.
[140] Luz Claudio,et al. Ultrastructural features of the blood-brain barrier in biopsy tissue from Alzheimer's disease patients , 1995, Acta Neuropathologica.
[141] M. Dehouck,et al. Hypoxia Increases the Susceptibility to Oxidant Stress and the Permeability of the Blood‐Brain Barrier Endothelial Cell Monolayer , 1995, Journal of neurochemistry.
[142] D. Butterfield,et al. Brain Regional Correspondence Between Alzheimer's Disease Histopathology and Biomarkers of Protein Oxidation , 1995, Journal of neurochemistry.
[143] W. Pardridge,et al. Vector-mediated delivery of 125I-labeled beta-amyloid peptide A beta 1-40 through the blood-brain barrier and binding to Alzheimer disease amyloid of the A beta 1-40/vector complex. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[144] G. W. Pace,et al. The role of oxidative stress in HIV disease. , 1995, Free radical biology & medicine.
[145] W. D. Ehmann,et al. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease , 1995, Neurology.
[146] P. Hedera,et al. Differential degeneration of the cerebral microvasculature in Alzheimer's disease. , 1995, Neuroreport.
[147] M. Dohadwala,et al. Exogenous tat protein activates central nervous system-derived endothelial cells , 1994, Journal of Neuroimmunology.
[148] A. Favier,et al. Antioxidant status and lipid peroxidation in patients infected with HIV. , 1994, Chemico-biological interactions.
[149] W. Risau,et al. Modulation of tight junction structure in blood-brain barrier endothelial cells. Effects of tissue culture, second messengers and cocultured astrocytes. , 1994, Journal of cell science.
[150] B. Zlokovic,et al. Blood-brain barrier transport of circulating Alzheimer's amyloid beta. , 1993, Biochemical and biophysical research communications.
[151] M. Itoh,et al. Occludin: a novel integral membrane protein localizing at tight junctions , 1993, The Journal of cell biology.
[152] J. Firth,et al. Immunohistochemical localization of adherens junction components in blood-brain barrier microvessels of the rat. , 1993, Journal of cell science.
[153] B E Kendall,et al. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. , 1990, Brain : a journal of neurology.
[154] N J Abbott,et al. Electrical resistance across the blood‐brain barrier in anaesthetized rats: a developmental study. , 1990, The Journal of physiology.
[155] R. Crystal,et al. SYSTEMIC GLUTATHIONE DEFICIENCY IN SYMPTOM-FREE HIV-SEROPOSITIVE INDIVIDUALS , 1989, The Lancet.
[156] F. Zemlan,et al. Superoxide dismutase activity in Alzheimer's disease: possible mechanism for paired helical filament formation , 1989, Brain Research.
[157] H. Wolburg,et al. Freeze-fracture analysis of endothelial cell membranes in rabbit carotid arteries subjected to short-term atherogenic stimuli , 1988, Virchows Archiv. B, Cell pathology including molecular pathology.
[158] I Hüttner,et al. Fracture faces of cell junctions in cerebral endothelium during normal and hyperosmotic conditions. , 1984, Laboratory investigation; a journal of technical methods and pathology.
[159] S. Olesen,et al. Electrical resistance of brain microvascular endothelium , 1982, Brain Research.
[160] Hartwig Wolburg,et al. Choroid plexus: biology and pathology , 2009, Acta Neuropathologica.
[161] E. Peterhans. Reactive oxygen species and nitric oxide in viral diseases , 2007, Biological Trace Element Research.
[162] Shailendra Giri,et al. GSNO attenuates EAE disease by S‐nitrosylation‐mediated modulation of endothelial‐monocyte interactions , 2007, Glia.
[163] E. Hansson,et al. Astrocyte–endothelial interactions at the blood–brain barrier , 2006, Nature Reviews Neuroscience.
[164] B. Engelhardt,et al. The Blood-Brain Barrier in EAE , 2005 .
[165] H. Wolburg,et al. Involvement of the choroid plexus in central nervous system inflammation , 2001, Microscopy research and technique.
[166] G. Comi,et al. Immunological markers in multiple sclerosis , 2000, Neurological Sciences.
[167] W R Markesbery,et al. Oxidative stress hypothesis in Alzheimer's disease. , 1997, Free radical biology & medicine.
[168] H. McFarland,et al. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. , 1995, Critical reviews in clinical laboratory sciences.